|
LanoxicapsDrug - Lanoxicaps The trade name of the product as shown on the labeling.
Dosage -
CAPSULE; ORAL
Active Ingredient(s) -
Digoxin
Strength -
0.05MG
Applicant -
SMITHKLINE BEECHAM
New Drug Application (NDA) Number -
018118
Product Number -
002
Therapeutic Equivalence (TE) Code -
Approval Date -
Jul 26, 1982
Reference Listed Drug (RLD) -
No
Type -
RX
Applicant Full Name -
Smithkline Beecham Corp Dba Glaxosmithkline
Lanoxicaps
Diflunisal 250mg Tablet; Oral
Diflunisal 500mg Tablet; Oral Dolobid 250mg Tablet; Oral Dolobid 500mg Tablet; Oral Crystodigin 0.2mg/ml Injectable; Injection Lanoxicaps 0.05mg Capsule; Oral Diflunisal 500mg Tablet; Oral Diflunisal 500mg Tablet; Oral Diflunisal 250mg Tablet; Oral Diflunisal 500mg Tablet; Oral NewDrugInformation |